Chemistry of Bridged Vitamin K Model Compounds
| dc.contributor.advisor | Lewis, David E. | |
| dc.contributor.author | Anderson, Katherine M. | |
| dc.contributor.author | Tsogtbaatar, Enkhtuul | |
| dc.date.accessioned | 2012-09-21T13:29:32Z | |
| dc.date.available | 2012-09-21T13:29:32Z | |
| dc.date.issued | 2012-04 | |
| dc.description | Color poster with text, graphs, diagrams, and charts. | en |
| dc.description.abstract | Warfarin (Coumadin) has been in extensive clinical use since 1954. Although widely prescribed, warfarin is associated with a high incidence of adverse drug events (ADEs). This study continues research begun in 2009 when two vitamin K analogues (UWEC-K1 and UWEC-K2) that can potentially act as a warfarin agonist, were discovered. | en |
| dc.description.sponsorship | University of Wisconsin--Eau Claire Office of Research and Sponsored Programs; WiSys Technology Foundation. | en |
| dc.identifier.uri | http://digital.library.wisc.edu/1793/62975 | |
| dc.language.iso | en_US | en |
| dc.relation.ispartofseries | USGZE AS589 | en |
| dc.subject | Chemistry--Experiments | en |
| dc.subject | Vitamin K--Derivatives | en |
| dc.subject | Anticoagulants (Medicine) | en |
| dc.subject | Posters | en |
| dc.title | Chemistry of Bridged Vitamin K Model Compounds | en |
| dc.type | Presentation | en |